“…In the last few years, several radiomics studies have been presented, ranging from tumor classification and phenotyping, to modeling of locoregional control, and prognostication of future outcomes (Morin et al 2018). Specific quantitative radiomics modeling studies were performed on a comprehensive list of tumor sites, including head and neck (Leijenaar et al 2015, Wong et al 2016), lung (Lee et al 2017, Thawani et al 2018, breast (Giannini et al 2017, Valdora et al 2018, liver (Saini et al 2019), colorectal (Rosati et al 2018, Giannini et al 2019, cervix (Anbumani 2018), prostate (Vignati et al 2015, Chen et al 2019, soft tissues (Peeken et al 2019), and brain (Grossmann et al 2017). To improve the model robustness, radiomics studies should involve multiple institutions, each one with specific imaging acquisition protocols (Li et al 2016) and radiological devices from diverse vendors and different radiomics tools (Liu et al 2016, Gnep et al 2017, Summers 2017.…”